Alcon Price to Free Cash Flow Ratio 2019-2024 | ALC

  • Alcon average price to free cash flow ratio for 2024 was 56.97, a 72.38% decline from 2023.
  • Alcon average price to free cash flow ratio for 2023 was 206.25, a 48.15% decline from 2022.
  • Alcon average price to free cash flow ratio for 2022 was 397.79, a 291.06% decline from 2021.

Price to free cash flow ratio can be defined as

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Annual Chart

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$216.7B
Thermo Fisher Scientific (TMO)$203.1B
Edwards Lifesciences (EW)$44B
IDEXX Laboratories (IDXX)$36.9B
DexCom (DXCM)$35B
IQVIA Holdings (IQV)$34.6B
Mettler-Toledo (MTD)$27.3B
Waters (WAT)$22.4B
STERIS (STE)$21.8B
SONOVA HOLDING (SONVY)$19.6B
Hologic (HOLX)$14.4B
Fresenius Medical Care AG KGaA (FMS)$13.6B
Penumbra (PEN)$11.7B
Sysmex ADR (SSMXY)$11.5B
Globus Medical (GMED)$11.5B
Masimo (MASI)$9.6B
Glaukos (GKOS)$8.9B
Teleflex (TFX)$8.1B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.5B
Veracyte (VCYT)$3.3B
Nihon Kohden (NHNKY)$2.7B
TransMedics (TMDX)$2.7B
LivaNova (LIVN)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$1.7B
Alphatec Holdings (ATEC)$1.5B
Pulse Biosciences (PLSE)$1.2B